Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Coya Therapeutics Inc (COYA)

Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coya Therapeutics Inc 5850 San Felipe St Suite 500 HOUSTON TX 77057 USA

www.coyatherapeutics.com Employees: 8 P: 800-587-8170

Description:

Coya Therapeutics Inc. is a clinical-stage biotechnology company. It involved in developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells to target systemic inflammation and neuroinflammation. The company's therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. Coya Therapeutics Inc. is based in HOUSTON.

Key Statistics

Overview:

Market Capitalization, $K 100,743
Enterprise Value, $K 68,113
Shares Outstanding, K 16,707
Annual Sales, $ 6,000 K
Annual Net Income, $ -7,990 K
Last Quarter Sales, $ 3,430 K
Last Quarter Net Income, $ -2,890 K
EBIT, $ -16,450 K
EBITDA, $ -16,420 K
60-Month Beta 0.46
% of Insider Shareholders 12.00%
% of Institutional Shareholders 39.75%
Float, K 14,702
% Float 88.00%
Short Volume Ratio 0.29

Growth:

1-Year Return 23.99%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/06/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -0.73
EPS Growth vs. Prev Qtr -36.84%
EPS Growth vs. Prev Year 23.53%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

COYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.63%
Return-on-Assets % -27.76%
Profit Margin % -133.17%
Debt/Equity 0.00
Price/Sales 16.90
Price/Cash Flow N/A
Price/Book 2.89
Book Value/Share 2.41
Interest Coverage -0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar